AIBIOS logo

AIBIOS Funding & Investors

AIBIOS has designed and developed a series of novel small molecules which modulate both the innate (macrophages) and adaptive immune system to treat therapeutic indications of Gastroenterology, Respiratory, and Neurological diseases.

aibios.com

Total Amount Raised: $7,862,328

AIBIOS Funding Rounds

  • Seed

    4,608,029 JPY

    Seed Investors

    SBI Investment Co.
  • Seed

    3,254,299 JPY

Funding info provided by Diffbot.